CSF1 and rheumatoid arthritis: Importantly, IL-34 is known to directly promote osteoclast formation like CSF-1 (53) and may upregulate the expression of the receptor activator of nuclear factor (NF)-κB-ligand (RANKL) for the progression of osteoclastogenesis in RA (21, 53–55).